The incidence of multiple primary tumours increases with age and due to multiple other factors as environmental and genetic predisposition. The authors describe a case of a 77-year-old female patient with diagnosis in September 2009 of colon mucinous adenocarcinoma. She was submitted to surgery, considered R1 and adjuvant chemotherapy. Six months after treatment she had abdominal recurrence on a nodular lesion in peritoneal fat. The patient was submitted to surgery and did multiple courses of systemic treatment. She underwent cytoreductive surgery with hyperthermic chemotherapy, too. In December 2014 she presented a nodular lesion on the bladder and after excision, the histology confirmed a high-grade transitional cell carcinoma and she maintains treatment with endovesical BCG instillations. After that, she had no evidence of peritoneal disease progression. Besides the bad prognosis associated to peritoneal disease, our case report describes a long survival (5 years with no disease progression) in a patient with high risk at diagnosis to peritoneal recurrence. This case shows the importance of multimodal approach and the impact of locoregional treatment in localized metastatic disease.
Introduction
The incidence of multiple primary tumours increases with age and there are currently more cases reported, not only because of advances in treatment that lead to an increased in overall survival, but also because of better accuracy of diagnostic modalities that increases the rate of diagnosis. In addition, the rise of life expectancy, immunosuppression, viral infections, environmental factors and How to cite this paper: Pereira, F., Alpoim, T., Leitão, M. and Machado, M. genetic predisposition are potential additional factors for multiple carcinogenesis. Still, the risk factors like tobacco cannot be forgotten.
The authors describe a case of a patient with recurrent peritoneal metastasis of mucinous adenocarcinoma of ascending colon, submitted to multimodal treatment with stable disease after 5 years and a transitional cell bladder carcinoma that is currently with no evidence of disease.
Case
A 77-year-old female patient, with a medical history of hypertension, obesity and active smoking, was submitted in September 2009 to a right hemicolectomy due to mucinous adenocarcinoma of ascending colon. The tumour was staged as pT3 N0 M0, with the surgery considered R1, due to a positive radial surgical margin.
In multidisciplinary team, she was proposed to perform complementary che- 
Discussion
After a curative treatment of the primary colon cancer, 20% -30% will develop locoregional or systemic recurrence during the follow-up. The liver is the most common metastatic site, followed by peritoneal cavity, which has a big impact on prognosis. About half of patients with CRC will have disease recurrence as peritoneal metastasis and 25% of these will have peritoneal disease as the only site of metastatic disease. Median OS in metastatic CRC is 30 months, with improvement of therapeutic options, and up to 20% of patients treated with ChT are alive at 5-years. The colon cancer with peritoneal carcinomatosis prognosis is
The present case represents an example of metachronous peritoneal metastatis from primary colon cancer, with a long survival after multimodal approach, namely with HIPEC.
The introduction of aggressive cytoredutive procedures combined with intraperitoneal ChT promised to alter the prognosis of these patients. Some studies showed a benefit in OS with 5-year survival rates 20% -30% [3] . In a study, patients with metachronous peritoneal disease showed a median OS of 28 months with this approach [4] . Aggressive surgical cytoreduction with intraperitoneal chemotherapy has been applied to patients with isolated peritoneal carcinoma- HIPEC did not given a benefit in metastatic CRC outcomes [8] .
Peritoneal disease is diagnosed in advanced stage in most of patients. Laparotomy or laparoscopy is the gold standard to diagnosis metachronous peritoneal metastasis but is difficult to perform given this is an invasive option.
CT has a low sensitivity for little lesions (<5 mm). MRI and PET-CT show a better sensitivity and a better correlation with intraoperatively disease [9] [10].
However, given the difficult to diagnosis there are trials that try to support second-look surgery in high risk patients. Segelman et al. considered as risk factors to peritoneal disease: tumors in right colon, emergency surgery, surgery non-R0, incomplete lymphadenectomy (<12 nodes examined) [11] . Other risk factors described are: T4 disease, perforated cancer, ovarian metastases, and positive peritoneal fluid cytology [10] . Some authors concluded that prophylac- Besides the bad prognosis associated do peritoneal disease, our case report describes a long survival (5 years with no disease evidence) in a patient with high risk at diagnosis to peritoneal recurrence (right colon, R1 surgery, mucinous carcinoma). This case shows the importance of multimodal approach and the impact of locoregional treatment in localized metastatic disease. Another important question in this case is the importance of biopsy of recurrent disease. In an era of target therapy, the biopsy of metastasis had another importance to decide relatively to treatment. In addition, this case illustrates that another primary tumor could be differential diagnosis and we must think about this possibility, essentially in case of presence of risk factors.
